col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: Journal of Internal Medicine
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―16 Self-infection with speech aerosol may contribute to COVID-19 severity Poorna Kushalnagar, Carson C. Chow, Adriaan Bax
2 [GO] 2021―Jul―08 Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming Cecilie Bo Hansen, Ida Jarlhelt, Rasmus Bo Hasselbalch, Sebastian Rask Hamm, Kamille Fogh, Mia Marie Pries-Heje, et al. (+14)
3 [GO] 2021―Jul―08 Body weight, body composition and the risk of SARS-CoV-2 infection in a large population-based sample Mélanie Deschasaux-Tanguy, Laurent Bourhis, Xavier Lamballerie, Fabrice Carrat, Mathilde Touvier
4 [GO] 2021―Jul―08 Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients Inge K. Holden, Claus Bistrup, Anna Christine Nilsson, Janne Fuglsang Hansen, Rozeta Abazi, Jesper Rømhild Davidsen, et al. (+4)
5 [GO] 2021―Jun―16 Mucormycosis and glucose-regulated protein 78 in COVID-19: amenable to statin treatment? Alpo Vuorio, Petri T. Kovanen
6 [GO] 2021―Jun―10 Truths and fakes in the smell terminology during the COVID-19 outbreak B. Arana-Fernández, A. Santamaría-Gadea, F. Mariño-Sánchez, J. Mullol
7 [GO] 2021―Jun―09 Mental health and quality of life in COVID-19 survivors: a needed discussion Sophia De Moraes De Medeiros, Raílla Vandresen, Elonir Gomes, Eliane Mazzuco
8 [GO] 2021―Jun―09 Breathing, speaking, coughing or sneezing: What drives transmission of SARS-CoV-2? V. Stadnytskyi, P. Anfinrud, A. Bax
9 [GO] 2021―Jun―07 Lipoprotein(a) and SARS-CoV-2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events Silvia Di Maio, Claudia Lamina, Stefan Coassin, Lukas Forer, Reinhard Würzner, Sebastian Schönherr, Florian Kronenberg
10 [GO] 2021―Jun―04 Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns E. E. Christensen, M. J. Jørgensen, K. G. Nore, T. B. Dahl, K. Yang, T. Ranheim, et al. (+10)
11 [GO] 2021―May―28 What drives transmission of severe acute respiratory syndrome coronavirus 2? Jan Andersson
12 [GO] 2021―May―19 Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden X. Castro Dopico, S. Muschiol, M. Christian, L. Hanke, D. J. Sheward, N. F. Grinberg, et al. (+8)
13 [GO] 2021―Apr―27 Half-year follow-up of patients recovering from severe COVID-19: Analysis of symptoms and their risk factors Y. F. Shang, T. Liu, J. N. Yu, X. R. Xu, K. R. Zahid, Y. C. Wei, et al. (+2)
14 [GO] 2021―Apr―19 Cause of death based on systematic postmortem studies in patients with positive SARS-CoV2 tissue PCR during the COVID-19 pandemic Elena S. Romanova, Valery V. Vasilyev, Galina Startseva, Vadim Karev, Margarita G. Rybakova, Pyotr G. Platonov
15 [GO] 2021―Apr―12 SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden S. S. Hassan, Å. Seigerud, R. Abdirahman, L. S. Arroyo Mühr, S. Nordqvist Kleppe, E. Pin, et al. (+8)
16 [GO] 2021―Apr―06 Reply letter to: Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: Are concentrations required clinically achievable? J. L. Gálvez-Romero, J. Deveaux-Homs, F. A. Real-Ramírez, O. Palmeros-Rojas, S. Pedraza-Sánchez
17 [GO] 2021―Apr―05 Psychophysical evaluations are important, usefulness and usability approaches to study the smell disorder related to COVID-19 Sven Saussez, Stéphane Hans, Carlos M. Chiesa-Estomba, Jerome R. Lechien
18 [GO] 2021―Mar―31 Cholestatic liver injury in COVID-19 is a rare and distinct entity and is associated with increased mortality Ben L. Da, Kelly Suchman, Nitzan Roth, Anam Rizvi, Maria Vincent, Arvind J. Trindade, et al. (+2)
19 [GO] 2021―Mar―13 Post-acute cognitive and mental health outcomes amongst COVID-19 survivors: early findings and a call for further investigation T. Vannorsdall, E. S. Oh
20 [GO] 2021―Mar―13 Impact of COVID-19 pandemic on the medical activities of the Directorate of Health and Hygiene, Vatican City State Massimo Ralli, Andrea Arcangeli, Paolo Maurizio Soave, Luigi Carbone, Lucia Ercoli, Fabio De-Giorgio
21 [GO] 2021―Mar―02 Arterial stiffness in acute COVID-19 and potential associations with clinical outcome Sebastian Schnaubelt, Julia Oppenauer, Daniel Tihanyi, Markus Mueller, Eduardo Maldonado-Gonzalez, Sara Zejnilovic, et al. (+9)
22 [GO] 2021―Feb―26 Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable? X. Solanich, N. Padullés, J. Niubó, S. Videla, A. Antolí, G. Rocamora-Blanch, X. Corbella
23 [GO] 2021―Feb―10 Chest pain mimicking pulmonary embolism may be a common presentation of COVID-19 in ambulant patients without other typical features of infection Stephanie R Harrison, Joel RL Klassen, Charlie Bridgewood, Andrew Scarsbrook, Helena Marzo-Ortega, Dennis McGonagle
24 [GO] 2021―Feb―10 The development of preprints during the COVID-19 pandemic Andreas Älgå, Oskar Eriksson, Martin Nordberg
25 [GO] 2021―Feb―06 Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors Raúl Méndez, Vicent Balanzá-Martínez, Sussy C. Luperdi, Itziar Estrada, Ana Latorre, Paula González-Jiménez, et al. (+9)
26 [GO] 2021―Feb―03 Pathophysiological Mechanisms and Management of Patients with Long-time Anosmia related to COVID-19 Jerome R. Lechien, Carlos M. Chiesa-Estomba, Stéphane Hans, Sven Saussez
27 [GO] 2021―Feb―03 Clinical Features of Patients who had two COVID-19 Episodes: A European Multicenter Case-series Jerome R. Lechien, Carlos M. Chiesa-Estomba, Thomas Radulesco, Justin Michel, Luigi A. Varia, Serge D. Le Bon, et al. (+6)
28 [GO] 2021―Jan―29 Tocilizumab in COVID-19 interstitial pneumonia G. Pomponio, A. Ferrarini, M. Bonifazi, M. Moretti, A. Salvi, A. Giacometti, et al. (+16)
29 [GO] 2021―Jan―27 Blood Group A Epitopes do not Facilitate Entry of SARS-CoV-2 Johannes Schetelig, Henning Baldauf, Sarah Wendler, Falk Heidenreich, Ruben Real, Martin Kolditz, et al. (+12)
30 [GO] 2021―Jan―19 Long-term recovery from COVID-19 anosmia: promising findings and unanswered questions Locatello Luca Giovanni, Oreste Gallo
31 [GO] 2021―Jan―19 Outcomes of COVID-19 Positive Acute Coronary Syndrome Patients; a multisource Electronic Healthcare Records Study from England Muhammad Rashid, Jianhua Wu, Adam Timmis, Nick Curzen, Sarah Clarke, Azfar Zaman, et al. (+7)
32 [GO] 2021―Jan―16 Assessment of Thirty-Day Readmission Rate, Timing, Causes, and Predictors after Hospitalization with COVID-19 Ilhwan Yeo, Seunghyup Baek, JoonHyuk Kim, Hadya Elshakh, Angelina Voronina, Man Si Lou, et al. (+4)
33 [GO] 2021―Jan―16 Increased vulnerability to Covid-19 in chronic kidney disease Nicholas Carlson, Karl-Emil Nelveg-Kristensen, Ellen Freese Ballegaard, Bo Feldt-Rasmussen, Mads Hornum, Anne-Lise Kamper, et al. (+2)
34 [GO] 2021―Jan―10 Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage M. A. Wu, T. Fossali, L. Pandolfi, L. Carsana, D. Ottolina, V. Frangipane, et al. (+10)
35 [GO] 2021―Jan―07 Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients J. R. Lechien, C. M. Chiesa-Estomba, E. Beckers, V. Mustin, M. Ducarme, F. Journe, et al. (+7)
36 [GO] 2020―Dec―29 Chronic rhinosinusitis is associated with prolonged SARS-CoV2 RNA shedding in upper respiratory tract samples: A case-control study B Recalde-Zamacona, A Tomás-Velázquez, A Campo, B Satrústegui-Alzugaray, M Fernández-Alonso, M Iñigo, et al. (+9)
37 [GO] 2020―Dec―20 Gastrointestinal Bleeding in Hospitalized COVID-19 Patients: A Propensity Score Matched Cohort Study Arvind J Trindade, Stephanie Izard, Kevin Coppa, Jamie S Hirsch, Calvin Lee, Sanjaya K Satapathy, et al. (+3)
38 [GO] 2020―Dec―11 The association between blood groups and COVID-19 infection: a study from the UK Biobank Jufen Zhang, Pierpaolo Pellicori, Rudolph Schutte, John G. Cleland
39 [GO] 2020―Dec―04 Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease. A pilot study Jose Luis Galvez-Romero, Oscar Palmeros-Rojas, Fernando Antonio Real-Ramírez, Saúl Sánchez-Romero, Ramiro Tome-Maxil, María Patricia Ramírez-Sandoval, et al. (+18)
40 [GO] 2020―Dec―03 Tobacco smoking confers risk for severe COVID-19 unexplainable by pulmonary imaging J. Li, X. Long, Q. Zhang, X. Fang, N. Li, B. Fedorova, et al. (+4)
41 [GO] 2020―Dec―01 Direct oral anticoagulant use and risk of severe COVID-19 Benjamin Flam, Viktor Wintzell, Jonas F. Ludvigsson, Johan Mårtensson, Björn Pasternak
42 [GO] 2020―Nov―22 PCSK9 inhibitors for COVID-19: An opportunity to enhance the antiviral action of interferon in patients with hypercholesterolemia Alpo Vuorio, Petri T. Kovanen
43 [GO] 2020―Nov―19 ACE-Inhibitors, Angiotensin Receptor Blockers and Endothelial Injury in COVID-19 Simon Tetlow, Agnieszka Segiet-Swiecicka, Rebecca O’Sullivan, Sinead O’Halloran, Kelli Kalb, Charlotte Brathwaite-Shirley, et al. (+12)
44 [GO] 2020―Nov―09 Insights into Disparities Observed with COVID-19 John M. Carethers
45 [GO] 2020―Nov―03 A potential link between RAAS, obesity and atrial fibrillation in COVID-19 infection O. M. P. Jolobe
46 [GO] 2020―Oct―27 On the relationship between BCG coverage and national Covid-19 outcome: could “heterologous” herd immunity explain why some countries are better off? Maria Lerm
47 [GO] 2020―Oct―20 Thinking about tuberculosis in times of Covid-19 Rosarito Coronel Teixeira, Sarita Aguirre, Domingo Pérez Bejarano
48 [GO] 2020―Oct―20 Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis C. S. Kow, S. S. Hasan
49 [GO] 2020―Oct―09 Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial Maria Lucia L. Madariaga, Jenna J. Guthmiller, Stephen Schrantz, Maud O. Jansen, Chancey Christensen, Madan Kumar, et al. (+28)
50 [GO] 2020―Oct―06 The Impact of Novel Coronavirus COVID-19 on Non-Communicable Disease Patients and Health Systems: A Review Andrew Y. Chang, Mark R. Cullen, Robert A. Harrington, Michele Barry
51 [GO] 2020―Sep―25 Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement H Hoel, L Heggelund, DH Reikvam, B Stiksrud, T Ueland, AE Michelsen, et al. (+9)
52 [GO] 2020―Sep―25 Reply to “High frequency of Antiphospholipid Antibodies in Critically ill COVID-19 patients: a Link with Hypercoagulability?” L. Suárez-Pérez, R. Coto-Hernández, C. Suárez-Cuervo, L. Caminal-Montero
53 [GO] 2020―Sep―23 Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID-19: experience from London N. Vaid, M. Ardissino, T. A. N. Reed, J. Goodall, P. Utting, M. Miscampbell, et al. (+2)
54 [GO] 2020―Sep―22 Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers W. Liu, Y. Liu, Z. Xu, T. Jiang, Y. Kang, G. Zhu, Z. Chen
55 [GO] 2020―Aug―03 Use of the IL-6R Antagonist Tocilizumab in Hospitalized COVID-19 Patients Krish Patel, Ted A. Gooley, Neil Bailey, Megumi Bailey, Livia Hegerova, Ami Batchelder, et al. (+21)
56 [GO] 2020―Aug―03 Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study. Johannes Eimer, Jan Vesterbacka, Anna-Karin Svensson, Bertil Stojanovic, Charlotta Wagrell, Anders Sönnerborg, Piotr Nowak
57 [GO] 2020―Jul―30 COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? M. F. Landecho, J. R. Yuste, E. Gándara, P. Sunsundegui, J. Quiroga, A. B. Alcaide, A. García-Layana
58 [GO] 2020―Jul―22 Cytokine storm syndrome in coronavirus disease 2019: A narrative review Y.-M. Gao, G. Xu, B. Wang, B.-C. Liu
59 [GO] 2020―Jul―11 The link between Vitamin D and Covid-19: distinguishing facts from fiction Peter Bergman
60 [GO] 2020―Jul―02 Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2, and thrombosis (R1) Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, George Griffin, Rose Anne Kenny
61 [GO] 2020―Jul―01 Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor? H. Luxenburger, L. Sturm, P. Biever, S. Rieg, D. Duerschmied, M. Schultheiss, et al. (+3)
62 [GO] 2020―Jun―30 Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study Francisco Sanz Herrero, Francesc Puchades Gimeno, Pilar Ortega García, Carolina Ferrer Gómez, María Dolores Ocete Mochón, Miguel García Deltoro
63 [GO] 2020―Jun―25 SARS-CoV-2 and biomimetics: What saves the planet will save our health P Stenvinkel, J Painer, PG Shiels, A Bansal, S Fereidouni, B Natterson-Horowitz, et al. (+2)
64 [GO] 2020―Jun―19 Beating the odds with systematic individualized care Nationwide prospective follow-up of all patients with COVID-19 in Iceland D Helgason, E Eythorsson, LB Olafsdottir, T Agustsson, S Ingvarsdottir, S Sverrisdottir, et al. (+5)
65 [GO] 2020―Jun―12 High Frequency of Antiphospholipid Antibodies in Critically-ill COVID-19 Patients: a Link with Hypercoagulability? Marc Pineton de Chambrun, Corinne Frere, Makoto Miyara, Zahir Amoura, Isabelle Martin-Toutain, Alexis Mathian, et al. (+2)
66 [GO] 2020―Jun―07 Viral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID-19 Thrombotic Complications Claudia Mendoza-Pinto, Ricardo O. Escárcega, Mario García-Carrasco, David J.O. Bailey, Jose Luis Gálvez-Romero, Ricard Cervera
67 [GO] 2020―Jun―04 Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States Zaid Imam, Fadi Odish, Inayat Gill, Daniel O'Connor, Justin Armstrong, Aimen Vanood, et al. (+4)
68 [GO] 2020―May―28 Sex-based dimorphism in the SARS-CoV2 virulence L. Pala, F. Conforti
69 [GO] 2020―May―27 COVID-19 and Renin-Angiotensin system inhibition - role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy? Aneta Aleksova, Federico Ferro, Giulia Gagno, Chiara Cappelletto, Daniela Santon, Maddalena Rossi, et al. (+4)
70 [GO] 2020―May―26 Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America A. Anyane-Yeboa, T. Sato, A. Sakuraba
71 [GO] 2020―Apr―30 Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019 Jerome R. Lechien, Carlos M. Chiesa-Estomba, Sammy Place, Yves Van Laethem, Pierre Cabaraux, Quentin Mat, et al. (+50)
72 [GO] 2020―Apr―29 COVID-19 diagnosis and management: a comprehensive review Giuseppe Pascarella, Alessandro Strumia, Chiara Piliego, Federica Bruno, Romualdo Del Buono, Fabio Costa, et al. (+2)
73 [GO] 2020―Apr―15 Carving out a place for internal medicine during COVID-19 epidemic in Italy Marco Vincenzo Lenti, Gino Roberto Corazza, Antonio Di Sabatino
74 [GO] 2020―Apr―03 Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk Alpo Vuorio, Gerald F. Watts, Petri T. Kovanen
75 [GO] 2020―Mar―27 Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19) Jian Wu, Wei Li, Xiaowei Shi, Zhongming Chen, Bin Jiang, Jun Liu, et al. (+7)


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.017 sec